AKR1B10 and gastric cancer: Furthermore, AKR1B10 is now established as a promising cancer target (except for gastric cancers, where it is downregulated) [12,16], and the ubiquitously expressed AR can represent a problematic off-target, given its overall similarity with AKR1B10.